Click here for Great Britain and Northern Ireland Prescribing Information for MYLOTARG®▼ (gemtuzumab ozogamicin) and cytarabine.
Adverse event reporting information can be found at the bottom of the page.
A short video (3.03 duration) explaining
-MYLOTARG's mechanism of action
-Leading to the rationale of MYLOTARG's fractionated dosing schedule
-The resulting efficacy and safety data from the ALFA-0701 study
-Summary of the NICE recommendation
A quick video (03.26 duration) that covers all the key points related to the pivotal Phase III ALFA-0701 study
- Study Design
- Baseline characteristics
- Induction and Consolidation courses
- Primary endpoint: Event Free survival results by cytogenetic group
- Secondary endpoint: Relapse Free Survival results
- Adverse Events reported
This video (3.33 duration) aims to illustrate the concept of MRD by aggregating findings from different disease areas, studies and results. Its main focus is on Acute Lymphoblastic Leukaemia and data on Acute Myeloid Leukaemia is shown at time point 2.40.
This video covers:
-Definition of MRD
-Relevance: Complete remission
-Impact on Survival rates and patient outcomes
Download the pdf
AML, Acute Myeloid Leukaemia; MRD, measurable residual disease
Stay up to date with the latest relevant healthcare, medical and promotional information about medicines and vaccines promoted by Pfizer.
PP-PFE-GBR-2809. March 2021
Sign up now
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-3863. November 2021
OK, We will need you to sign in before we can determine if you are aligned with a Pﬁzer promotional colleague.This is an interstitial message to prompt a HCP before they login.
If you have already registered with pfizerpro.co.uk and select ‘yes’, you will be directed to the sign-in page where you will be required to enter your username and password.
Would you like to register or sign in now?